Previous studies confirmed that PMA-activated or variant of MEK (MEK-DD)-activated MEK-ERK signaling regulate PD-L1 expression via IFN-γ-induced STAT1 phosphorylation in multiple myeloma and triple-negative breast cancer (TNBC) [55, 56]. Here, MAP2K7 is linked to triple-negative breast carcinoma.